Change-sensitive Measurement of Adult Functional Outcomes in Developmental Disabilities
发育障碍成人功能结果的变化敏感测量
基本信息
- 批准号:10565683
- 负责人:
- 金额:$ 59.2万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2020
- 资助国家:美国
- 起止时间:2020-05-19 至 2025-02-28
- 项目状态:未结题
- 来源:
- 关键词:Adaptive BehaviorsAdultAgeCalibrationCaregiversCategoriesChildChildhoodClinicalClinical TrialsCommunitiesComprehensionDevelopmentDevelopmental DisabilitiesDiagnosisDimensionsDown SyndromeEmploymentEnsureEquipment and supply inventoriesEvaluationEvidence based treatmentFactor AnalysisFamilyFragile X SyndromeGroup HomesIndependent LivingIndividualInformation SystemsInpatientsIntellectual functioning disabilityInterventionIntervention StudiesKnowledgeLifeLonelinessMeasurementMeasuresMethodologyMethodsModelingMonitorMood DisordersNeurodevelopmental DisorderOccupationsOutcomeOutcome MeasureOutpatientsParentsParticipantPatient Outcomes AssessmentsPatient Self-ReportPatientsPopulationPropertyProxyPsychometricsPublic HealthReporterReportingResearchSamplingSchizophreniaSeveritiesSocial FunctioningSocial isolationSocietiesSymptomsTestingTimeUnderserved PopulationUnited States National Institutes of HealthValidity and Reliabilityadult with autism spectrum disorderautism spectrum disorderbiological sexcognitive interviewdesigndisabilityemotion dysregulationexperiencefunctional disabilityfunctional improvementfunctional outcomesimprovedneuropsychiatrynovelresponseservice providersskillssocialsocial deficitssoundsuccesstheoriestherapy developmenttreatment effecttreatment trialverbal
项目摘要
7. PROJECT SUMMARY/ABSTRACT
Developmental disabilities (DD), including autism spectrum disorder (ASD), Down syndrome, Fragile X
syndrome, and other intellectual and developmental disabilities are heterogeneous neurodevelopmental
disorders that place considerable burden on individuals, families, and society. Although most research on DD
has focused on children, these conditions are life-long with few established treatments to support functioning in
adulthood. As a result, many adults with DD experience significant functional impairment represented by low
rates of employment, severe social dysfunction and isolation, and a limited ability to live independently and
experience autonomy in adult life. The development of interventions to improve adult functional outcomes in
social, employment, and independent living domains across DD has lagged far behind those developed for
children. A key factor limiting the development of treatments to improve adult functioning in DD is the lack of
validated assessments of functional outcome applicable to adulthood. Current studies either use measures
relevant to childhood with limited applicability to and treatment sensitivity in adults, or fail to assess this
important domain, greatly restricting knowledge on how adult functioning can be improved in DD. We have
shown in preliminary studies with adults with ASD that it is possible to develop measures of functional outcome
in adulthood that have greater validity and are more sensitive to treatment effects than existing measures
adapted from childhood. In response to this major gap in adult outcome measurement in DD and PAR-18-039,
“Outcome Measures for Use in Treatment Trials of Individuals with Intellectual and Developmental Disabilities”,
this project proposes to use NIH PROMIS methods to develop and validate proxy- and self-report versions of
the Adult Functioning Scale (AFS) for assessing functional outcomes in social, employment, and independent
living domains in adults with DD. A pool of potential items will be generated based on our conceptual model,
functional outcome measures used in other populations, and input from expert and stakeholder panels. This
item pool will then be completed by two calibration samples: Proxy reporters (e.g., parents, clinicians, group
home staff) for 1000 adults with DD representative of the full range of verbal and intellectual functioning in DD
and 1000 self-reporting adults with DD (N = 500 with ASD, N = 500 with other DD). Advanced psychometric
analytics employing exploratory and confirmatory factor analysis and item response theory models will be used
to create final calibrated item banks (and static short forms) of the AFS suitable for broad use in clinical trials
across heterogeneous DD. The reliability and validity of the AFS caregiver and self-report versions will be
examined in the calibration samples, along with a 4-week retest subsample (N = 200). Sensitivity to treatment-
related changes will be assessed in longitudinal intervention studies of inpatient and outpatient samples of
adults with DD. The results will validate the first measure of functional outcome for use in clinical trials in adult
DD and will pave the way for treatment advances to improve functioning in this underserved population.
7。项目摘要/摘要
发育障碍(DD),包括自闭症谱系障碍(ASD),唐氏综合症,脆弱x
综合征以及其他智力和发育障碍是异质性神经发育
尽管大多数DD研究
这些条件专注于儿童,是终身的,很少有既定的治疗方法来支持功能
成年。结果,许多DD的成年人经历了较低的功能障碍
就业率,严重的社会功能障碍和孤立以及独立生活的能力有限
在成人生活中体验自治。开发干预措施以改善成人功能结果
DD各地的社会,就业和独立生活领域远远落后于为
孩子们。限制治疗发展以改善DD成人功能的关键因素是缺乏
经过验证的适用于成年的功能结果的评估。当前的研究要么使用措施
与童年有关,适用于成人的适用性和治疗敏感性有限,或者无法评估这一点
重要的领域,极大地限制了DD中如何改善成人功能的知识。我们有
在与ASD的成年人的初步研究中显示了可以开发功能结果的测量值
在成年后具有更大的有效性,对治疗效果更敏感
从童年开始改编。响应DD和PAR-18-039中成人结局测量中的这一主要差距,
“在智力和发育障碍的人的治疗试验中使用的结果措施”,
该项目建议使用NIH Promis方法来开发和验证代理和自我报告版本的
成人功能量表(AFS)用于评估社会,就业和独立的功能结果
DD成人的生活领域。根据我们的概念模型,将生成一批潜在项目
其他人群中使用的功能结果度量以及专家和利益相关者面板的投入。这
然后,项目池将通过两个校准样本完成:代理记者(例如,父母,临床医生,小组
家庭工作人员)1000名DD成年人,代表DD中的各种口头和智力功能
和1000名具有DD的自我报告的成年人(n = 500,ASD,n = 500与其他DD)。高级心理测量学
将使用采用探索性和确认因素分析和项目响应理论模型的分析(分析)
创建最终校准的物品库(和静态的简短形式),适用于临床试验的广泛使用
跨越异质的DD。 AFS护理人员和自我报告版本的可靠性和有效性将是
在校准样品中检查,以及4周的重新测试子样本(n = 200)。对治疗的敏感性
相关变化将在对住院和门诊样本的纵向干预研究中进行评估
成人DD。结果将验证在成人临床试验中使用功能结果的首次测量
DD并将为治疗方面的发展铺平道路,以改善服务不足的人群的功能。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
SHAUN M EACK其他文献
SHAUN M EACK的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('SHAUN M EACK', 18)}}的其他基金
Change-sensitive Measurement of Adult Functional Outcomes in Developmental Disabilities
发育障碍成人功能结果的变化敏感测量
- 批准号:
10358601 - 财政年份:2020
- 资助金额:
$ 59.2万 - 项目类别:
Cognitive Enhancement for Persistent Negative Symptoms in Schizophrenia
精神分裂症持续负面症状的认知增强
- 批准号:
10451712 - 财政年份:2019
- 资助金额:
$ 59.2万 - 项目类别:
Cognitive Enhancement for Persistent Negative Symptoms in Schizophrenia
精神分裂症持续负面症状的认知增强
- 批准号:
9804053 - 财政年份:2019
- 资助金额:
$ 59.2万 - 项目类别:
Cognitive Enhancement for Persistent Negative Symptoms in Schizophrenia
精神分裂症持续负面症状的认知增强
- 批准号:
10655377 - 财政年份:2019
- 资助金额:
$ 59.2万 - 项目类别:
Cognitive Enhancement for Persistent Negative Symptoms in Schizophrenia
精神分裂症持续负面症状的认知增强
- 批准号:
10197800 - 财政年份:2019
- 资助金额:
$ 59.2万 - 项目类别:
Cognitive Enhancement for Persistent Negative Symptoms in Schizophrenia
精神分裂症持续负面症状的认知增强
- 批准号:
10005475 - 财政年份:2019
- 资助金额:
$ 59.2万 - 项目类别:
Cognitive Enhancement Therapy for Adult Autism Spectrum Disorder
成人自闭症谱系障碍的认知增强疗法
- 批准号:
9248442 - 财政年份:2015
- 资助金额:
$ 59.2万 - 项目类别:
Long Term Impact of Early Cognitive Enhancement in Schizophrenia
早期认知增强对精神分裂症的长期影响
- 批准号:
8890341 - 财政年份:2015
- 资助金额:
$ 59.2万 - 项目类别:
Cognitive Enhancement Therapy for Adult Autism Spectrum Disorder
成人自闭症谱系障碍的认知增强疗法
- 批准号:
8979854 - 财政年份:2015
- 资助金额:
$ 59.2万 - 项目类别:
Social-Cognitive Rehabilitation and Brain Function in Early Schizophrenia
早期精神分裂症的社会认知康复和脑功能
- 批准号:
8537508 - 财政年份:2012
- 资助金额:
$ 59.2万 - 项目类别:
相似国自然基金
成人型弥漫性胶质瘤患者语言功能可塑性研究
- 批准号:82303926
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
MRI融合多组学特征量化高级别成人型弥漫性脑胶质瘤免疫微环境并预测术后复发风险的研究
- 批准号:82302160
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
成人免疫性血小板减少症(ITP)中血小板因子4(PF4)通过调节CD4+T淋巴细胞糖酵解水平影响Th17/Treg平衡的病理机制研究
- 批准号:82370133
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
SMC4/FoxO3a介导的CD38+HLA-DR+CD8+T细胞增殖在成人斯蒂尔病MAS发病中的作用研究
- 批准号:82302025
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
融合多源异构数据应用深度学习预测成人肺部感染病原体研究
- 批准号:82302311
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
相似海外基金
Computational and neural signatures of interoceptive learning in anorexia nervosa
神经性厌食症内感受学习的计算和神经特征
- 批准号:
10824044 - 财政年份:2024
- 资助金额:
$ 59.2万 - 项目类别:
Community reentry for older adults leaving prison with and without health limitations
有或没有健康限制的出狱老年人重返社区
- 批准号:
10741029 - 财政年份:2023
- 资助金额:
$ 59.2万 - 项目类别:
Computational and neurodevelopmental mechanisms of memory-guided decision-making
记忆引导决策的计算和神经发育机制
- 批准号:
10723314 - 财政年份:2023
- 资助金额:
$ 59.2万 - 项目类别:
Momentary Geospatial, Psychological, and Behavioral Risk for Substance Use in Young Adults Under Criminal Justice Supervision
刑事司法监督下的年轻人使用药物的瞬时地理空间、心理和行为风险
- 批准号:
10448749 - 财政年份:2022
- 资助金额:
$ 59.2万 - 项目类别:
Brainstem Trigeminal Mechanisms of Orofacial Pain
口面部疼痛的脑干三叉神经机制
- 批准号:
10598592 - 财政年份:2022
- 资助金额:
$ 59.2万 - 项目类别: